Astria Therapeutics's total assets for Q3 2024 were $361.64M, a decrease of -1.73% from the previous quarter. ATXS total liabilities were $19.98M for the fiscal quarter, a -4.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.